APA (7th ed.) Citation

Mhmud, H., Vermeulen, J. P., Tigchelaar-Besling, O. A. M., Verbraak, F. D., Barthelmes, D., Gillies, M., . . . Klaver, C. C. W. Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Mhmud, H., J. P. Vermeulen, O. A. M. Tigchelaar-Besling, F. D. Verbraak, D. Barthelmes, M. Gillies, T. L. Ponsioen, and Caroline C. W. Klaver. Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF. Adis, Springer Healthcare.

MLA (9th ed.) Citation

Mhmud, H., et al. Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF. Adis, Springer Healthcare.